Cipla Share Price Target 2024, 2025, 2027, 2030, 2040

If you think about which share will be best for investment in recent times then you should know about Cipla Share Price Target. Today in our blog we will explain the basic idea about Cipla Share Price Target 2024, 2025, 2027, 2030, 2040. We did the research and took advice from experts to make this blog about the company’s growth, performance, etc.

Cipla Share Price Target is a trading share in the share market. In this article, we will discuss the company’s financial growth, the business policy of the company, the shareholding pattern of the company, and the forecast share price yearly. We use expert data and analysis to understand the Cipla Share Price Target 2024 to 2040.

What Is Cipla Limited Company?

Cipla Limited is an Indian multinational pharmaceutical company that was established in the year 1935. The headquarters of the company is situated in Mumbai. The company mainly manufactures and supplies pharmaceutical drugs, generic drugs, dietary supplements, protein supplements, vaccines, contact lenses, etc.

Overview About Cipla Limited Company

Cipla Company has 48 manufacturing locations all over India and the company supplies its products in 86 countries. Cipla Company mainly focuses on the medication process of diabetics, arthritis, cardiovascular disease, respiratory disease, depression, and many other medical states. The company was primarily known as Chemical, Industrial & Pharmaceutical Laboratories, after that in the year 1984 the company changed its name to Cipla Limited.

Financial Data Analysis Of Cipla Limited

We need a basic idea about the company’s PE ratio, return on assets, current ratio, and return on equity. In the below portion, we discuss the performance of the company. Cipla Share Price Target also depended upon the ratio described below.

History Of Cipla Share Price Target From 2024 to 2040

Cipla Share Price Target is a bullish trend in the share market. Cipla Share is under both the Indian Stock Exchange BSE (Bombay Stock Exchange) and NSE (National Stock Exchange). The last 6 month’s share growth was +196.20 (15.31%), the last 1 year’s share growth was +475.95 (47.51%), the last 5 year’s share growth was +927.75 (168.68%) and the maximum share growth was +1,454.28 (6,196.34%).

Cipla Share Price return amount was 46.78% in the last 1 year, the last 3 years’ share price return amount was 52.45%, last 5 year’s share price return amount was 167.45%. Cipla Share always gives good returns to investors. If anyone wants to invest in the share it will be profitable long-term. Let’s have a look at the Cipla Share Price Target from 2024 to 2040.

Also Read – Sun Pharma Share Price Target

Cipla Share Price Target 2024

Cipla Company first introduced respiratory disease medicine in the year 1976 with the Salbutamol Tablet also introduced an inhaler in India in the year 1978. The company introduces new products for Chronic Obstructive Pulmonary Disease, Allergic Rhinitis, and many other diseases like lung cancer, Pulmonary Arterial Hypertension, etc. For Allergic Rhinitis the company also introduces Nasal Steroids, Nasal Sprays, Oral antihistamines, etc.

The sales growth of the company is not so good. In the last 5 years sales growth was 6.89%, in the last 3 years it became 7.85% and in the last 1 year it became 2.98%. The net sales amount of the company was ₹3,612.85 Crore in March 2023 which increased to ₹4,185.70 Crore in March 2024. If we look at the Cipla Share Price Target 2024 forecast, the 1st Price Target is ₹1,425.85 and the 2nd Price Target is ₹1,685.23.

Cipla Share Price Target 2025

Cipla Generic provides different types of essential medicine which include 26 therapeutic categories include 150 brands. Cipla Company provides different types of Vitamins in the form of Syrup and tablets like Cipcal HD Syrup, Cipcal 250, Cipcal 500 tablets, etc. Steroid tablets like Nestacort 6 were also innovated by Cipla Company. The PAT margin of the company was ₹2,512 Crore in the year 2020-21 which became ₹2,645 Crore in the year 2021-22.

The profit growth of the company was 12.56% in the last 5 years which decreased to 2.78% in the last 3 years and in the last 1 year, it became -16.23%. The Net Profit amount was ₹2,985.42 Crore in March 2022 which became ₹2,547.12 Crore in March 2023. The operating profit amount was ₹3,745.52 Crore in March 2022 which became ₹3,845.65 Crore in March 2023. If we look at the Cipla Share Price Target 2025 forecast, the 1st Price Target is ₹1,714.45 and the 2nd Price Target is ₹1,956.45.

Cipla Share Price Target 2027

For Thyroid Treatment the company also provides drugs like Thyropic 25 Tab, Thyrocip 150 Tabs, etc. In the International Market, the company also spread its business, from North America the company earned 20% revenue from its total revenue, and in South America, the company earned 17% of the revenue. Cipla Company also provides drugs through an internet healthcare app and provides medicine in the form of home delivery services, through consultation treating more than 1,43,123 patients yearly.

As the company spreads its business outside the company the FII investor percentage of the company is good which is 26% to 27% which is a very good side for the company’s growth. The promoter holding capacity of the company is average which is 33% to 34% which means many good investor wants to invest in the share. If we look at the Cipla Share Price Target 2027 forecast, the 1st Price Target is ₹2,245.56 and the 2nd Price Target is ₹2,478.52.

Also Read – Suven Pharma Share Price Target

Cipla Share Price Target 2030

Cipla Company successfully overcame the COVID-19 pandemic situation by playing an important role. Supplying masks, sanitizers, Instant COVID-19 medicine, COVID-19 vaccine, etc which are also exported to different foreign countries for more development of the company’s economic condition. Cipla Company gives importance to the R&D sector, in the year 2022-23 the invested amount by the company was ₹1,425 Crore which increased 5.17% compared to the previous year.

The ROE percentage of the company was 13.01% in the last 5 years which decreased to 11.52% in the last 3 years and in the last 1 year, it became 10.85%. The ROCE percentage of the company was 17.52% in the last 5 years which became 16.23% in the last 3 years and in the last 1 year it became 15.42%. If we look at the Cipla Share Price Target 2030 forecast, the 1st Price Target is ₹3,145.52 and the 2nd Price Target is ₹3,354.78.

Cipla Share Price Target 2040

Cipla Company also provides Cancer treatment provides 32 anti-cancer treatments. The company also provides nontech-based cancer products such as paclitaxel injection. In the last financial year, Cipla Company ranked 2 in the sales of inhalers. The 4 most usable Cipla Brands ranked within the top 50 brands in the Indian pharma market. The company is also attached to many hospital industries for providing drugs.

The total expenditure amount was ₹2,985.45 Crore in March 2023 which became ₹3,345.23 Crore in March 2024. The EBITDA amount was ₹4,625 Crore in the year 2021-22 which became ₹5,256 Crore in the year 2022-23. If we look at the Cipla Share Price Target 2040 forecast, the 1st Price Target is ₹5,654.12 and the 2nd Price Target is ₹5,812.63.

Peer’s Company of Cipla Company

• Aarati Drugs
• Aayush Food
• Abbott India
• Advanced Enzyme
• Aarey Drugs

Investors Types And Ratio Of Cipla Company

There are mainly four main Types of Investors in Cipla Company. The company’s growth also depended upon the ratio of investors who invested in the share.

Promoters Holding

Promoters Holding means how much capital is invested by company promoters (company owner) through overall capital. Cipla Company’s promoter holding capacity is 33.40%.

Public Holding

Public Investors are individuals who invest in the public market for profit in the future (large and small companies). Cipla Company’s public holding capacity is 16.20%.

FII

Foreign Institutional Investors are those big companies that invest in different countries company. Cipla Company’s FII is 26.10%.

DII

Domestic Institutional Investors (like Insurance, companies mutual funds) who invest in their own country. Cipla Company’s DII is 24.30%.

Advantages and Disadvantages Of Cipla Share

Every share has some advantages and some disadvantages also. So, the Cipla Share Price Target also has some advantages and disadvantages.

Advantages

• The company is virtually debt-free and has a good interest cover ratio which is 129.23.
• The company has an efficient cash conversation cycle of 5.26 days.
• The company has good cash flow management, PAT stands for 1.10.
• The Book Value amount has increased per share in the last 2 years.
• The company has a good operating margin of 21.99% in the last 5 days.

Disadvantages

• The profit growth of the company is not so good which is 2.78% in the last 3 years.
• The revenue growth of the company is very poor which is 7.85% in the last 3 years.

Also Read – Yatharth Hospital Share Price Target

FAQ

Conclusion

Hopefully, www.sharetargethub.com will help you gain some basic ideas about the Cipla Share Price Target. By doing the research and taking advice from expertise we ensure that on a long-term basis, Cipla Share Price Target may reach a very high position. Cipla Company is related to the pharmaceutical Sector. So the demand for this sector also increases which helps the share to gain profit in the future.

If you think this website will be helpful for you then you can share it. If you have any questions please let us know through the comment box we will try to reply to your questions and solve your problem. Thanks for visiting this website and thanks for being with us.

Disclaimer – We are not SEBI-registered advisors. A financial market is always risky to anyone. This website is only for training and educational purposes. So before investing, we are requested to discuss certified expertise. We will not be responsible for anyone’s profit or loss.